Interventional Spine said it has tagged ex-ConMed executive and 25-year medical veteran Joseph Darling as its new vice president and COO.
Darling spent 7 years with ConMed, serving as the COO, executive veep and prez of ConMed Linvatec until February this year. Before his time at ConMed, Darling worked with Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter International and Abbott Laboratories.
“Joe brings a wealth of experience and solid credentials to Interventional Spine’s management team. His leadership and strategic focus that spans his career will be a great addition to our management team. We intend to call upon his years of experience, and to capitalize on his strengths in strategic planning, market development, and his global knowledge to expand our efforts world wide. His proven ability to build teams will benefit our organization as we continue to grow,” CEO Walter Cuevas said in a press release.
“I am very pleased to take on this expanded role with Interventional Spine as we continue to develop our strategy in the spine market, I look forward to working closely with Walter and the management team to expand our presence and strength in this important market,” Darling said.
Global Kinetics said it picked up ex-Medtronic veterans Peter Lynch and Phil Roeser. Lynch was brought on as head of global market access and Roeser as executive president of North America.
TearLab said it has named ex-Alcon Lab’s veep Wes Brazell as its new CFO, replacing William Dumencu who will stay on as a consultant until the end of 2015.
CasMed (NSDQ:CASM) said its chief commercial officer Brian Wagner will step down effective July 10. Wagner joined the company in 2013, coming from a chief marketing officer position with Philips Imaging Systems.